GAM
THC icon

Goldentree Asset Management’s Tenet Healthcare THC Stock Holding History

Goldentree Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-179,183
Closed -$31.5M – 31
2025
Q2 		$31.5M Buy
+179,183
New +$27M 3.04% 12
2024
Q2 		– Sell
-248,519
Closed -$26.1M – 46
2024
Q1 		$26.1M Sell
248,519
-263,004
-51% -$23.6M 2.08% 20
2023
Q4 		$38.7M Buy
+511,523
New +$32.4M 4.01% 11
2023
Q2 		– Sell
-401,584
Closed -$23.9M – 43
2023
Q1 		$23.9M Sell
401,584
-35,553
-8% -$1.98M 2.24% 18
2022
Q4 		$21.3M Buy
437,137
+60,876
+16% +$2.81M 1.71% 15
2022
Q3 		$19.4M Buy
+376,261
New +$22.3M 1.28% 18
2022
Q1 		– Sell
-657,284
Closed -$53.7M – 45
2021
Q4 		$53.7M Buy
657,284
+183,185
+39% +$13.4M 2.34% 11
2021
Q3 		$31.5M Buy
+474,099
New +$33.6M 1.3% 21
2020
Q2 		– Sell
-182,884
Closed -$2.63M – 27
2020
Q1 		$2.63M Buy
+182,884
New +$5.25M 0.49% 19
2019
Q4 		– Sell
-840,000
Closed -$18.6M – 25
2019
Q3 		$18.6M Buy
+840,000
New +$17.9M 2.69% 11

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldentree Asset Management's THC Position: Q3 2025 in Review

Goldentree Asset Management sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 179,183 shares — an estimated $31.5M sold.

Goldentree Asset Management first reported a position in THC in Q3 2019 and held it in 10 quarters. The position peaked at $53.7M in Q4 2021. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Goldentree Asset Management reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Goldentree Asset Management sold 179,183 Tenet Healthcare shares in Q3 2025, an estimated $31.5M.
  • Goldentree Asset Management first reported a position in Tenet Healthcare in Q3 2019 and held it in 10 quarters.
  • Goldentree Asset Management's Tenet Healthcare position peaked at $53.7M in Q4 2021.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Goldentree Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.